{"abstract":"The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pharmacy Compounding Advisory Committee (PCAC). The general function of the committee is to provide advice on scientific, technical, and medical issues concerning drug compounding, as well as any other product for which FDA has regulatory responsibility, and to make appropriate recommendations to the Agency. The meeting will be open to the public.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/10/05/2016-24085.html","cfr_references":[],"citation":"81 FR 69062","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on November 3, 2016, from 8:30 a.m. to 4:30 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2016-N-0001"],"dockets":[],"document_number":"2016-24085","effective_on":null,"end_page":69063,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/10/05/2016-24085.xml","html_url":"https://www.federalregister.gov/documents/2016/10/05/2016-24085/pharmacy-compounding-advisory-committee-notice-of-meeting","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-24085?publication_date=2016-10-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-10-05/2016-24085/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":375,"last_updated":"2026-08-26 10:15:07 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-10-05/pdf/2016-24085.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-24085.pdf?1475585171","publication_date":"2016-10-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/10/05/2016-24085.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2016-N-0001","supporting_documents_count":0,"docket_id":"FDA-2016-N-0001","regulation_id_number":null,"title":"Advisory Committee, Workshops, and Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc)","checked_regulationsdotgov_at":"2016-10-25T06:00:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":69062,"subtype":null,"title":"Pharmacy Compounding Advisory Committee; Notice of Meeting","toc_doc":"Pharmacy Compounding Advisory Committee","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":81}